UNSPSC 51343005: Stavudine and lamivudine and nevirapine
Commodity
Code facts
- Part of
-
-
51000000
-
51340000
- 51343000
-
51340000
-
51000000
- NIGP codes
- 1
UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.
NIGP codes for 51343005
| NIGP code |
|---|
| 26908 Anti-Infective Agents |
Definition
This classification denotes a combination drug for treatment of HIV. The first component of this combination drug is a reverse transcriptase inhibitor, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier BO9LE4QFZF. European Medicines Agency schedules Stavudine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10642MIG. Stavudine generally arises in the molecular formula C10H12N2O4. The term STAVUDINE is an International Non-Proprietary Name or INN.
Read the full definition
STAVUDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO. The second component of this drug is a reverse transcriptase inhibitor with the molecular formula C8H11N3O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2T8Q726O95, chemically known as 4-amino-1-((2r,5s)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-2(1h)-pyrimidinone but generally known as lamivudine, which bears US NIH Compound Identifier 60825.
European Medicines Agency schedules Lamivudine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08392MIG. The term LAMIVUDINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 6, No, 3 1992, List 32). World Health Organization schedules lamivudine in its Anatomical Therapeutic Chemical (ATC) Classification. LAMIVUDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.
The third component of this combination drug is a reverse transcriptase inhibitor, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 99DK7FVK1H. European Medicines Agency schedules Nevirapine, anhydrous in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB25191. Nevirapine generally arises in the molecular formula C15H14N4O. The term 'nevirapine' is a European Pharmacopoeia designation.
NEVIRAPINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.
About UNSPSC 51343005
UNSPSC 51343005 Stavudine and lamivudine and nevirapine is a Commodity code that nominally designates antiretroviral pharmaceutical combinations, but recent state and local procurement activity under this code shows little alignment with the code's stated scope. The two recent opportunities tagged to this code involve unrelated pharmaceutical products: an Illinois Department of Public Health contract for Doxycycline Hyclate and Ciprofloxacin Hydrochloride antibiotics, and a Seminole County, Florida solicitation for Naloxone and drug deactivation systems. Neither opportunity involves the stavudine, lamivudine, or nevirapine formulations the code nominally describes. State and local health departments and counties are the issuing bodies visible in the recent record.
The geographic activity spans Illinois and Florida based on the two recent opportunities posted between June and August 2026. The Illinois Department of Public Health awarded a pharmaceutical warehouse piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC (Solicitation 26482DPHPREPDB53392, IFB, award completed August 28, 2026 for $2,999,999.11 across the life of the contract including renewal options). Seminole County, Florida released an IFB (IFB60459723LAS) on June 30, 2026 for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries, though the response deadline of July 26, 2023 is inconsistent with the posting date. The code shows limited relevant recent activity; the mismatch between the code's nominal scope and the pharmaceutical products actually being procured suggests procurement offices may be applying this code inconsistently or the data source contains classification errors.
Quick answers
What is UNSPSC 51343005?
UNSPSC 51343005 is Stavudine and lamivudine and nevirapine, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.
Which NIGP codes match UNSPSC 51343005?
UNSPSC 51343005 maps to 1 NIGP code, 26908 Anti-Infective Agents.
On GovTribe
See everything under UNSPSC 51343005
- State & local contract opportunities, awards and contract vehicles under this code
- Contacts who buy under this code
- Ask GovTribe AI about this code